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We introduce a method for analyzing small interfering RNA (siRNA) genetic screens based entirely on
off-target effects. Using a screen for members of the Wnt pathway, we demonstrate that this method
identifies known pathway components, some of which are not present in the screening library. This
techniquecanbeappliedtosiRNAscreenresultsretroactivelytoconfirmpositivesandidentifygenesmissed
using conventional methods for on-target gene selection.
L
arge-scale siRNA screening is an increasingly popular method of interrogating signaling pathways both to
identify relevant genes and to discover novel drug targets. siRNA screens typically involve transfecting small
numbers of cells with a library designed to target the entire genome or some subset (such as a set of genes
coding for theoretically druggable domains)
1. The systematic knockdown of each gene enables high-throughput
loss-of-function analysis by assessing pathway dependent phenotypes as measured through changes in the
appearance of specific markers or induction of reporter constructs (Fig. 1a).
Unfortunately, siRNA screens have demonstrated a high false positive rate
2. Researchers typically perform
labor-intensive follow-up work on hundreds of hits to confirm a handful of relevant genes. Many false positives
arelikelyduetooff-targeteffects
3,4,whereinpartialcomplementaritybetweenansiRNAandmultipletranscripts,
typically in the 39UTR, results in their down-regulation, adding unintended silencing to the screen (Fig. 1b).
Previous work on attenuating off-target effects has largely focused on identifying lower-risk sequences, intro-
duction of chemically modified siRNAs, or use of multiple siRNA sequences in additional screens
5.
Results
In order to understand and exploit the off-target effects present in siRNA screening data, we implemented a
predictive model of down-regulation due to siRNA off-targeting. Existing predictors are microRNA-related and
often use conservation or other criteria not applicable to siRNA off-targeting
6. We trained a simple linear model
specific for siRNAs using published gene expression profiles in which off-targeting mediated by the seed (posi-
tions 2–8 of the guide strand) has been detected
7. Our model for off-target seed-based down-regulation is:
On,k~b1:PMzb2:M1zb3:M8zb4:M18zb5:30UTRLength
The model includes four types of seed matches, or reverse complementarity between the guide strand seed
sequence and the 39UTR of the transcript: PM, perfect match to guide bases 2–7 followed by adenine opposite
base1;M1,noadenineoppositebase1;M8,mismatchoppositebase1;andM18,withbothterminalmismatches.
We calculate as predictive variables the number of times a particular match-type occurs between the seed
sequence of the siRNA n and the 39UTR of the transcript k. In addition, we use the length of the 39UTR as a
predictive variable, since in our analyses longer 39UTRs were correlated with up-regulation of transcripts in the
absence ofsiRNAseedmatches.Up-regulation ofgeneswithlong39UTRs andalowerdensityofsiRNAmatches
has been previously observed in the literature
8. Model parameters (b) are derived from linear regression against
the mean log ratio of mRNA expression data (see Fig. 2, Supplementary Data Set 1, and Methods).
WehypothesizethatsiRNAsoff-targetingtopathwaymemberscaninpartexplainthephenotypesobservedin
genome-wide screens (Fig. 1c). To investigate this, we introduce Haystack, a new computational method for
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SCIENTIFIC REPORTS | 2 : 428 | DOI: 10.1038/srep00428 1identifying the most statistically significant genes that explain screen
results, based entirely on off-target effects. First, we predict all On,k,
the off-target down-regulation of every transcript k by every siRNA
n. Second, for each transcript we calculate the significance of cor-
relation between the predicted down-regulation by every siRNA to
the siRNAs’ screen results z, using a t-test. Third, the most statist-
ically significant transcript is selected and a linear parameter ak is
estimated, approximating z as a function ak * Ok 1 c. Finally, the
residualbetweenzandthepredictedvaluesofzinthislinearmodelis
calculated and the next transcript is selected via the significance of
the correlation of each remaining Ok to the residual. In this stepwise
manner, the most statistically significant transcripts are selected and
added iteratively as features to a linear model, until no transcript has
a Bonferonni-corrected correlation p-value less than 0.01. The final
model can be viewed as predicting the phenotypic score associated
with an siRNA zn as a linear combination of the predicted off-target
effects of siRNA n on a set of transcripts K (with some constant
intercept term c):
zn~cz
X K
k~1
akOn,k
We assess the transcripts selected based on ak, the magnitude of
the off-target effects on transcript k in explaining the screening
results. The directionality of ak indicates the effect (either positive
or negative) thatdown-regulation of each transcript has on the assay
readout.
We applied Haystack to 19,815 siRNAs used in screening 6,605
theoretically druggable genes for activity in the Wnt/b-catenin sig-
naling pathway (Supplementary Data Set 2). The Wnt/b-catenin
pathway is constitutively active in many human cancers. To screen
for novel factors in the Wnt/b-catenin pathway, HT1080 sarcoma
cells were engineered to contain a firefly luciferase reporter cou-
pled to a b-catenin-driven promoter, activated in the screen by
conditioned media containing Wnt-3a. A control EF1a-driven
Renilla luciferase reporter was used for normalization. Three
siRNAs per gene were transfected individually into the reporter cell
line in three separate screens. We calculated z-scores for the siRNAs
from the log ratio of reporter intensities.
Table 1 lists, ordered by p-value, the top 10 genes included in the
model built via Haystack from the siRNA screens in combination.
Predicted activities per gene correlated well between screens when
analyzed separately (Fig. 3). Supplementary Table 1 contains all 61
hits identified. In the case of the Wnt pathway, a large number of
‘‘canonical’’ pathway members have been previously identified. To
measure pathway enrichment in screening results, we used 158 Wnt
related genes from the KEGG pathway database
9. Of the top 10 most
statistically significant transcripts, 6 (LEF1, AXIN2, CCND1, RAC1,
CTNNB1, and LRP6) are in the KEGG list of Wnt pathway genes, a
remarkablelevelofenrichment(P,3.7e-11;hypergeometrictestfor
enrichment).
We reviewed literature on the genes present in Table 1 but not
listed in KEGG to check for other associations to the Wnt pathway.
SUMO2, the third most statistically significant hit, has been iden-
tified as sumoylating and repressing LEF1
10. Consistent with that
role, its parameter estimate in the regression indicates that down-
regulation of SUMO2 increases reporter activity. Another hit
(Supplementary Data Set 3), SENP7, has been shown to reverse
the sumoylation of SUMO2/3
11, and accordingly the regression ana-
lysis shows that its down-regulation decreases Wnt reporter activity.
Finally, the transcription factor POU4F2 (BRN3B) is involved in
bothcelldevelopment
12and cancer
13,as isthe Wnt pathway, making
a role for POU4F2 in Wnt signaling seem plausible.
Itisworthnotingthatthreetranscriptsidentifiedinthetop10hits
(RAC1, CLEC18B, and POU4F2) did not have siRNAs designed
against them in the druggable library screened here. Although
RAC1 is not included in the library, it is found by Haystack analysis
and is a canonical member of the Wnt pathway. Since off-target
Figure 1 | siRNA on-targeting and off-targeting to genes in a hypothetical pathway. (a) On-target model correctly infers gene B as a pathway member
duetoon-targeteffects, depictedbythe solidarrowfromthe siRNA(blue)togeneB.Extensive base-pairing betweenthesiRNAandtargetgeneB results
insilencing.(b)Afalse-positiveresultincorrectlyinfersnon-pathwaygeneCasapathwaymemberbyneglectingoff-targetingeffects,depictedbydashed
gray arrows from the siRNA (red) to pathway genes B and F. (c) Haystack explains screen results as a linear combination of the predicted off-targeting
effects,depictedbydashedgrayarrowsfromthesiRNA(red)topathwaygenesBandF.Imperfectbase-pairingbetweensiRNA(red)and39UTRregionof
off-target genes results in down-regulation.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 428 | DOI: 10.1038/srep00428 2Figure 2 | TrainingansiRNA off-targetmodel. The seedsequenceforan siRNAisdefined hereasthereverse complement ofthe heptamer atthe 59 end
of the guide strand of the siRNA (bases 2–8), appended with an ‘‘A’’. Four orthogonal match types are defined between the seed sequence of the guide
(antisense) strand anda given 39UTR: PM (octamer; perfect match), M1 (heptamer, mismatch on base 1 ofthe guide seed), M8 (heptamer, mismatch of
base 8 of the guide seed), M18 (mismatch of bases 1 and 8 of the guide seed). The sequence of these match types are defined for two example siRNAs,
PIK3CB-6338 and PIK3CB-6340. The length of a 39UTR is also used as a predictive feature, as it has been empirically observed to be correlated with up-
regulationwhentherearenomatchesofansiRNAtothe39UTR(Figure1).Thesefeatureswerethenusedinalinearregressionagainstthemeanlogratio
of the transcript from gene expression profiles in which the siRNAs were transfected into cells (profiles GSM134511 and GSM134512 respectively,
downloadedfromGEO).Thelinearmodelstrainedfromthesetwodatasetswerethencross-validatedoneachother,todemonstratemodelsderivedfrom
onesiRNAcanbesuccessfullyappliedtoanother.Eachmodelwasusedtopredictsignificantly(p-value,.01)down-regulatedtranscriptsinthedataset/
siRNAthatitwasnotderivedfrom,andtheresultsofthiscross-validationweredisplayedasROCcurves.Thedashedlineineachgraphcorrespondstothe
expected performance of a random model (AUC50.5). Finally, the data sets were merged to generate a final off- target model.
www.nature.com/scientificreports
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evant genes for which no siRNA exists in our screening library.
Discussion
Haystack analysis can be applied to any previous siRNA screen of
sufficient scale, preferably with normally distributed scores, to con-
firm hits via an orthogonal metric or to identify genes originally
missedduetolibrary composition.Unfortunately, itisnotyetstand-
ard for raw data from siRNA screens to be published, as microarray
expression profiling data are. Consequently, Haystack is available as
a download (http://rnai.nih.gov/haystack/Software.zip) or web-based
service (http://rnai.nih.gov/haystack/) for researchers who have per-
formed screens to analyze their data and confirm hits or find new hits
potentially missed by ‘‘on-target’’ analysis.
Finally, although a genome-specific siRNA library would be ex-
pected to have relatively poor on-target performance against cells
from another organism, a large-scale library would likely have the
seed sequence diversity required to perform Haystack analysis on
any organism having a RNA interference pathway. Thus Haystack
also presents a novel solution for siRNA screens in cells from organ-
isms for which no library is yet available.
Methods
Software used. Statistical analysis and graphs were generated using R
14. ROC curves
were generated using the ROCR package
15. The kernel density plot of 39UTR length
distributions was generated using the sm package
16.
39UTR sequences. Human 39UTR sequences (a total of 34268 sequences) from the
Refseq
17 collection were downloaded using the UCSC table browser
18. These
sequenceswerematchedagainsttheIDsforthegeneexpressiondatasetsforpurposes
of training the off-target model. To create the matrix of predicted off-target effects,
170 sequences that were shorter than 20 nucleotides and 2554 sequences that were
non-coding (NR prefix in accession) were removed. In addition, 10852 sequences
were removed because they were identical to a 39UTR already included. The
remaining 20692 39UTR sequences were used to create the off-target matrix.
Gene expression data. Expression data previously shown to be enriched with
transcripts that were down-regulated and contained seed matches to transfected
siRNAs in their 39 UTRs
7 were downloaded from the GEO website
19 and used in
training and testing the siRNA off-target model.
Training and testing the off-target model. Features for predicting siRNA off-target
down regulation were selected based on the previously observed importance of the
seed sequence
7,20 (bases 2–7 of the guide strand) and the observed preference for
adenine opposite from base 1of the guide strand
21.Althoughall possiblematch types
to the seed including one or two base-mismatch were considered, only four match
types(PM,M1,M8,M18)werestatisticallysignificantpredictorsofdown-regulation.
The reverse complement of the guide strand seed sequence followed by an adenine
forms a perfect match (PM) and mismatches to base 1 (M1), base 8 (M8), or both
(M18) form the four different seed match types selected. In addition, we used the
lengthofthe39UTRasapredictivevariable,sinceinouranalyseslonger39UTRswere
correlated with up-regulation of transcripts in the absence of siRNA seed matches.
Linearmodels predicting thedown-regulation ofatranscriptbased onthenumberof
each match type observed in the 39UTR and the total length of the 39UTR were
trained separately on gene expression data from the transfection of two different
siRNAs. These models were then cross-validated on the data not used to train them,
and finally the data sets (Supplementary Data Set 1) were combined to train a final
model (Fig. 2).
Table 1 | Top10moststatisticallysignificantgenesidentifiedbyHaystackAnalysis.GenesthatarepartofthecanonicalWntpathwayarein
bold (LEF1, AXIN2, CCND1, RAC1, CTNNB1, and LRP6). Z-scores and their respective ranks for three different siRNAs designed against
these genes are displayed. Scores and ranks in the top 10% are in bold, and would be considered hits. Some z-scores are not present (--)
because the library used in the screen does not contain any siRNAs designed against these genes
Gene Parameter Estimate from Haystack p-value
Single 1 Single 2 Single 3
Z-score Rank Z-Score Rank Z-Score Rank
LEF1 251.01 2.90E-62 212.38 749 214.39 387 27.47 3450
AXIN2 26.49 3.14E-20 12.85 633 3.15 10696 0.58 17900
SUMO2 34.61 9.77E-15 7.92 3033 9.68 1790 9.24 2075
CCND1 215.28 4.26E-14 24.22 8233 212.54 705 213.05 591
SLC25A23 214.72 3.76E-13 28.88 2300 29.94 1638 1.92 13800
RAC1 19.37 1.41E-11 -- -- -- -- -- --
CLEC18B 243.02 1.96E-11 -- -- -- -- -- --
CTNNB1 227.45 5.02E-11 245.4 1 20.15 19344 234.27 2
POU4F2 17.21 2.59E-10 -- -- -- -- -- --
LRP6 28.65 6.56E-09 219.75 68 225.61 11 211.65 973
Figure 3 | Reproducibilityoft-statistics. T-statisticscalculatedinthefirststepofthemethod,usedtoevaluatethenull-hypothesisthatthepredictedoff-
target effects of the library on a given transcript are not correlated with the screening results. Large t-statistics in either the positive or negative direction
indicatethatthereissignificantcorrelationoranti-correlationrespectivelybetweentheoff-targeteffectsonthetranscriptandthescreeningresults.These
correlations are reproducible across subsets of the data, in this case, across the data from each of the three single siRNAs designed against each gene.
www.nature.com/scientificreports
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Sigma–Proligo. siRNAs were designed to have sequence asymmetry to increase
efficacy and had less than 17 bp of complementarity to other genes
22. The library
contains 6605 sets of 3 siRNAs each designed to theoretically druggable genes.
siRNA screening data. Data used to evaluate these methods came from a genome-
scale siRNA screen
23,24 in the HT1080 sarcoma cell line for genes involved in the
Wnt/b-catenin pathway. Cells were engineered to contain a luciferase reporter
coupled to a b-catenin-driven promoter, which was subsequently activated with
conditioned media containing Wnt-3a. In primary screening, both a whole genome
and a druggable library were screened in pools with at least three replicates. In
addition, all single siRNAs contained within the druggable pools were assayed
separately. All assay results were normalized to a plate-based non-targeted control to
yield a z-score.
Correlation and statistical significance calculations. Correlation between the
screenresultsz(orlatertheresidual)andthe predictedoff-targeteffectsofthelibrary
on a given transcript were calculated using the formula:
rk~
P N
n~1
znOn,k{n z Ok
n{1 ðÞ szsOk
where On,k is our prediction of the off-target down-regulation of each mRNA tran-
script k by each siRNA n. The t-statistic of the null hypothesis that the correlation is
actually zero is then calculated as:
tk~
rk ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{r2
k
    
n{2 ðÞ
q
with the associated p-value of the null hypothesis being derived from the Student’s t-
distribution with n-2 degrees of freedom, where n is the number of siRNA screening
results.
Since the off-target model makes the same predictions for every siRNA with the
sameheptamerseedsequence(bases2–8oftheguidestrand)andthereareonly16384
possible heptamers, we can pre-compute the predictions for each 39UTR. Using this
simplification,wedonotneedaseparatesetofpredictionsforeachsiRNAlibrary.To
use this pre-computed matrix to calculate Haystack t-statistics for a set of single
siRNAsusedinascreen,wefirstcalculatethemeanassayresponseforallsiRNAsthat
contain the same seed sequence. We then calculate the weighted correlation coef-
ficient and corresponding t-statistic between the predicted down-regulation caused
by each seed sequence and the mean observed response of that seed sequence in the
assay(orthe residualin latersteps),where theweights arethe number ofoccurrences
ofeachseedsequenceinthelibrary.Aweightedlinearregressionisperformedateach
iterationbetweentheselectedOkandthemeanassayresponseforeachseed.Likewise,
it is possible to use Haystack analysis on siRNA screens performed using pools by
calculatingthemeanresponseoftheassayforallpoolsinwhichoneofthecomponent
siRNAs has a given seed sequence and then weighting the correlation coefficient and
linear regression by the number of pools in the screen containing that seed sequence.
PERL and R code for pre-computing off-target predictions from a FASTA formatted
file of 39UTRs and calculating these t-statistics from mean seed sequence responses
are supplied from the Haystack website (http://rnai.nih.gov/haystack/Software.zip).
Validation of statistical techniques. The validity of using Pearson’s correlation
coefficient, the t-statistic and corresponding p-value to estimate the statistical
significance of non-normally distributed vectors has been a subject of some debate
25,
andseemstodependonthesizeofthevectorsandtheparticularcharacteristicsofthe
distributions considered. Although the z-scores generated from this set of screening
data are fairly normal in their distribution, the predictions of off-target effects to
which we are comparing them are non-normal. Therefore, we tested how well the
Student’s T distribution was approximating the distribution expected at random.
Z-scores from the druggable singles collection were randomly permuted against
their original heptamers. Fig. 4a shows a q-q plot of the t-statistics resulting from the
random permutation (in red) and the distribution observed for the original non-
permuteddata(inblue)comparedtotheStudent’sT-distributionwith10029degrees
of freedom (which is the length of the vectors for which the null hypothesis of zero
correlation is being tested, minus 2). As expected, the quantiles from our randomly
permuteddatatrackwellagainsttheStudent’st-distribution,whilethenon-permuted
data does not.
We next performed 1000 random permutations of the same data set and noted
transcriptsforwhichtheBonferronicorrectedp-value(calculatedfromthet-statistic)
was less than 0.01. Fig. 4b shows the distribution of false positives observed in 1000
trials. Although the majority of permutations did not result in any false positives,
20.3% of the permutations resulted in one or more false positives, which is signifi-
cantly greater than the 1% of false positives that we would expect if Student’s t-
distribution perfectly modeled the null hypothesis we are testing. The mean number
of false positives per random permutation was 0.263. In comparison to the 1217
putative positives observed for the original, non-permuted data, we judge the risk of
falsepositives tobesmall and errorin thisapproximation tobeacceptable,given that
the alternative would be to use non-parametric statistics or random permutation to
estimate p-values, either of which would significantly reduce our sensitivity and
increase the already significant computation time required.
Figure 4 | Validation of Statistical Framework. (a) A q-q plot of t-
statistics generated by random permutation of the druggable singles data
(in red) and non- randomized data (in blue). (b) Incidences and number
of false positives in 1000 random permutations the druggable singles data.
(c) 39UTR length distribution for false positives (red) and positives (blue)
compared to the overall distribution of 39UTR lengths (black).
www.nature.com/scientificreports
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39UTR length for the false positives identified in the 1000 random permutations
versusalltranscriptsanalyzedandthosetranscriptsidentifiedaspositivesinthenon-
permuted data (Fig. 4c). There is a significant shift towards smaller 39UTRs in the set
of false positives compared to the general population. This may indicate that the
approximation of the Student’s T distribution is slightly less valid for shorter tran-
scripts. Similarly, transcripts identified as positives in the non-permuted set are
shifted towards longer 39UTRs than the set of all 39UTRs. We believe this may be the
case because true positives with short 39UTRs have a smaller ‘‘off-target signature’’,
being down-regulated by fewer siRNAs off-target and thus presenting less signal for
detection by the method. It is also possible that short 39UTRs represent incorrect or
incomplete sequences. Thus we conclude that transcripts with short 39UTRs may be
more likely to be both false positives and false negatives in Haystack analysis.
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